# Evaluation of Spironolactone Efficacy in Patient with Rheumatoid Arthritis (RA)

> **NCT05092984** · PHASE3 · RECRUITING · sponsor: **University Hospital, Strasbourg, France** · enrollment: 154 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Spironolactone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05092984
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-22
- **Primary completion:** 2026-03
- **Final completion:** 2026-03
- **Target enrollment:** 154 (ESTIMATED)
- **Last updated:** 2025-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05092984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05092984, "Evaluation of Spironolactone Efficacy in Patient with Rheumatoid Arthritis (RA)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05092984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*